PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.\', \'Obesity and Comorbidities Research Center, University of Campinas, Campinas, São Paulo, Brazil.\', \'School of Nursing, University of Campinas, Campinas, São Paulo, Brazil.\', \'Department of Surgery, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.\', \'Department of Radiology, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.\', \'Department of Statistics, Institute of Mathematics, Statistics, and Scientific Computation, University of Campinas, Campinas, São Paulo, Brazil.\', \'Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil. lavellos@unicamp.br.\', \'Obesity and Comorbidities Research Center, University of Campinas, Campinas, São Paulo, Brazil. lavellos@unicamp.br.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05027-9
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33472675
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all